Boston Scientific (BSX) knew of pacemaker battery issues for years, NYT reports; issues linked to at least 7 deaths and 800+ injuries

Newsquawk StaffPublished
Newsquawk headlinesUTC

Every headline is on the live feed 20 minutes before this site.

US lawmakers said to be in talks about energy permitting reforms

US Energy Secretary Wright says Trump admin has no plan to implement restrictions on oil and gas exports

Boston Scientific (BSX) knew of pacemaker battery issues for years, NYT reports; issues linked to at least 7 deaths and 800+ injuries

Israel Channel 12 says fire and rescue teams completely control two fires in Haifa refineries as a result of falling shrapnel, Al Jazeera reports

Chevron (CVX) restarts jet fuel unit at its 275k bpd El Segundo refinery five months after fire

On the Newsquawk feed at , 20 minutes before this page.

Use the PlatformFree. No signup, no card.

Context

This report suggests significant regulatory and reputational risks for Boston Scientific, given the longstanding knowledge of pacemaker battery issues that have reportedly resulted in fatalities and injuries. Investors should consider how this might impact BSX's stock price, potential legal ramifications, and scrutiny from regulatory bodies, which could lead to increased costs or limitations on sales strategies in the health care equipment sector.

Related headlines

The feed had this first.

Use the Platform